Jean-Pierre Bizzari's Net Worth
$9.11 Million
Who is Jean-Pierre Bizzari?
Jean-Pierre Bizzari has an estimated net worth of $9.11 Million. This is based on reported shares across multiple companies, which include PIERIS PHARMACEUTICALS, INC., HALOZYME THERAPEUTICS, INC., Celator Pharmaceuticals Inc, Aprea Therapeutics, Inc., and ADC Therapeutics SA.
SEC CIK
Jean-Pierre Bizzari's CIK is 0001630914
Past Insider Trading and Trends
2023 was Jean-Pierre Bizzari's most active year for acquiring shares with 3 total transactions. Jean-Pierre Bizzari's most active month to acquire stocks was the month of April. 2021 was Jean-Pierre Bizzari's most active year for disposing of shares, totalling 1 transactions. Jean-Pierre Bizzari's most active month to dispose stocks was the month of May. 2024 saw Jean-Pierre Bizzari paying a total of $0.00 for 40,000 shares, this is the most they've acquired in one year. In 2021 Jean-Pierre Bizzari cashed out on 35,000 shares for a total of $1,435,455.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PIERIS PHARMACEUTICALS, INC. (PIRS) Snapshot price: $15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HALOZYME THERAPEUTICS, INC. (HALO) Snapshot price: $59.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.73% | 8.06K |
—
|
—
| 66.81K |
May 5
| |||
Form 4
| +11.81% | 6.21K |
—
|
—
| 58.75K |
May 5
| |||
Form 4
| -39.98% | -35.00K |
$41.01 | -$1,435,455.00 | 52.54K |
Aug 25
| |||
Form 4
| +6.35% | 5.23K |
—
|
—
| 87.54K |
May 5
| |||
Form 4
| +12.01% | 8.83K |
—
|
—
| 82.31K |
Apr 30
| |||
Form 4
| +19.85% | 12.17K |
—
|
—
| 73.48K |
May 2
| |||
Form 4
| +20.34% | 10.36K |
—
|
—
| 61.31K |
May 2
| |||
Form 4
| +38.40% | 14.13K |
—
|
—
| 50.95K |
May 4
| |||
Form 4
| +121.61% | 20.2K |
—
|
—
| 36.81K |
May 4
| |||
Form 4
| +383.33% | 13.18K |
—
|
—
| 16.61K |
May 6
| |||
Form 4
|
∞
| 3.44K |
—
|
—
| 3.44K |
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Celator Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aprea Therapeutics, Inc. (APRE) Snapshot price: $3.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADC Therapeutics SA (ADCT) Snapshot price: $2.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.09% | -7.00K |
$2.89 | -$20,215.55 | 79.5K |
Jun 17
| |||
Form 4
| +86.03% | 40K |
—
|
—
| 86.5K |
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||